| Previous Close | 85.30 |
| Open | 85.82 |
| Bid | 82.00 x 400 |
| Ask | 86.74 x 500 |
| Day's Range | 85.38 - 86.78 |
| 52 Week Range | 53.78 - 104.71 |
| Volume | 425,799 |
| Avg. Volume | 508,264 |
| Market Cap | 4.49B |
| Beta | 1.24 |
| PE Ratio (TTM) | 14.68 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 0.00 (0.00%) |
| Ex-Dividend Date | 2012-11-23 |
| 1y Target Est | N/A |
Capital Cube•12 hours agoMasimo Corp. – Value Analysis (NASDAQ:MASI) : August 17, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Masimo Corp. a score of 88. Our analysis is based on comparing Masimo Corp. with the following peers – ResMed Inc., Royal Philips NV Sponsored ADR, Thermo Fisher Scientific Inc., Natus Medical Incorporated, Owens & Minor, Inc., Cardinal Health, Inc., Universal Forest Products, Inc., CAS Medical Systems, ... Read more (Read more...)
- Zacks•23 hours ago
McKesson Banks on Distribution Business Amid Pricing Woes
McKesson (MCK) entered fiscal 2018 with an assumption of branded inflation in the mid-single digits. Pricing pressure in the independent retail pharmacy channel is a headwind.
- Zacks•23 hours ago
BioTelemetry Hits a 52-Week High: What's Driving the Stock?
BioTelemetry (BEAT) is putting efforts in product innovation through research and development. The company recently announced the acquisition of LifeWatch AG in a deal valued at about $280 million.
